日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZNF683(+) NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment.

ZNF683(+) NK 细胞通过重塑免疫微环境来控制晚期 HPSCC 的化疗敏感性。

Li Guo, Xiao Wenhao, Wu Haijun, Liu Chao, Gong Liang, Zhang Haoyu, Shao Zhuo, Bai Jing, Xia Xuefeng, Yi Xin, Wang Yunyun, Lu Shanhong, She Li, Wang Juncheng, Zhu Gangcai, Zhou Xiaojuan, Wang Wenmei, Shen Liangfang, Zhang Nu, Wang Xingwei, Huang Donghai, Hou Junwei, Qiu Yuanzheng, Zhang Xin, Hung Mien-Chie, Liu Yong

Enhanced coordination interaction with multi-site binding ligands for efficient and stable perovskite solar cells

增强与多位点结合配体的配位相互作用,可提高钙钛矿太阳能电池的效率和稳定性

Nie, Riming; Zhang, Peikun; Gao, Jiaxing; Wang, Cheng; Chu, Weicun; Li, Luyao; Wang, Kaiyu; Qian, Dongmin; Lin, Fanrong; Xia, Xuefeng; Wu, Yong; Chao, Lingfeng; Miao, Chunyang; Zhao, Xiaoming; Guo, Wanlin; Zhang, Zhuhua

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

作者更正:评估基于人类白细胞抗原的新抗原呈递以确定泛癌对免疫疗法的反应

Han, Jiefei; Dong, Yiting; Zhu, Xiuli; Reuben, Alexandre; Zhang, Jianjun; Xu, Jiachen; Bai, Hua; Duan, Jianchun; Wan, Rui; Zhao, Jie; Bai, Jing; Xia, Xuefeng; Yi, Xin; Cheng, Chao; Wang, Jie; Wang, Zhijie

Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter study

循环肿瘤DNA在预测和监测接受多模式治疗的局部晚期直肠癌患者的生存期中的应用:一项前瞻性多中心研究的长期结果

Zhou, Jiaolin; Li, Lifeng; Liu, Yuxin; Jia, Wenzhuo; Liu, Qian; Gao, Xuan; Wu, Aiwen; Wu, Bin; Shen, Zhanlong; Wang, Zhenjun; Han, Jiagang; Niu, Beizhan; Gong, Yuhua; Guan, Yanfang; Zhou, Jianfeng; Xue, Huadan; Zhou, Weixun; Hu, Ke; Lu, Junyang; Xu, Lai; Xia, Xuefeng; Yi, Xin; Yang, Ling; Lin, Guole

DNA methylation mediates the immunosuppressive tumour microenvironment in metastatic endometrial clear cell carcinoma.

DNA甲基化介导转移性子宫内膜透明细胞癌的免疫抑制性肿瘤微环境。

Jia Huiqing, Chen Yang, Ma Guofeng, Xu Sicong, Zhang Xiangyan, Chang Lianpeng, Yang Ping, Xiao Yujing, Xia Xuefeng, Zhang Shukun, Tang Huaxiao, Mou Yilin, Zhang Lina, Wang Haoyan, Bai Jing, Yi Xin, Xing Xiaoming

Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies

用于实体恶性肿瘤分子残留病灶监测的个性化肿瘤信息循环肿瘤DNA检测

Liu, Liping; Liang, WenHua; Cao, WuQiang; Wang, Hongke; Liang, HengRui; Huang, Liyan; Zhong, Danman; Gao, Wei; Deng, Qiuhua; Zhang, Yan; Zeng, XiaoLing; Wang, Wei; Huang, Jun; Yang, Chao; Peng, GuiLin; Zheng, XunMei; Ma, JiaXin; Du, XinHua; Cui, Liang; Guan, Yanfang; Bai, Jing; Xia, Xuefeng; Yi, Xin; He, Jianxing

Correction to: NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR

更正:NADPH氧化酶4通过产生活性氧和诱导EGFR来调节胃癌细胞的抗凋亡能力

Du, Shangce; Miao, Ji; Zhu, Zhouting; Xu, En; Shi, Linsen; Ai, Shichao; Wang, Feng; Kang, Xing; Chen, Hong; Lu, Xiaofeng; Guan, Wenxian; Xia, Xuefeng

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis

阿特珠单抗联合贝伐珠单抗治疗不可切除或转移性黏膜黑色素瘤患者:3年生存率更新及多组学分析

Dai, Jie; Xu, Tianxiao; Li, Lifeng; Fang, Meiyu; Lin, Jing; Cao, Jun; Bai, Xue; Li, Caili; Wei, Xiaoting; Gu, Junjie; Liu, Yaoyao; Gao, Xuan; Xia, Xuefeng; Guo, Jun; Chen, Yu; Mao, Lili; Si, Lu

cfDNA methylation detection as potential liquid biopsy of multiple organ injury in myocarditis patients

cfDNA甲基化检测作为心肌炎患者多器官损伤的潜在液体活检手段

Zhao, Yangchao; Wang, Yujia; Zhao, Xi; Zhang, Xin; Wang, Haoyan; Cui, Liang; Wang, Huifen; Zhu, Weiwei; Li, Boyan; Zhou, Yanjun; Li, Jun; Fu, Guowei; Zhou, Yiheng; Sun, Pengwei; Bai, Jing; Xia, Xuefeng; Yi, Xin; Yang, Ling; Chen, Chaoqun; Tang, Junnan; Li, Ang; Yu, Zujiang

Development and application of a whole transcriptome sequencing assay for the detection of gene fusions in clinical cancer specimens

开发和应用全转录组测序检测方法检测临床癌症标本中的基因融合

Zhao, Songchen; Du, Xinhua; Zhang, Yan; Bai, Jing; Meng, Lu; Li, Xuefei; Ma, Jiaxin; Sheng, HeYu; Fu, Xiaorui; Guan, Yanfang; Yi, Yuting; Yang, Ling; Xia, Xuefeng; Yi, Xin; Tan, Xinxin; Zhou, Caicun